New Approval Management functionality coming to SafeScript NSW
New Approval Management functionality coming to SafeScript NSW
SafeScript NSW, the state’s real time prescription monitoring (RPTM) system, will have new functionality in early November.
The new approval management functionality offers an efficient and centralised solution which will streamline the authority/approval management process to prescribe and supply certain high-risk medicines.
Why introduce this new functionality?
The new functionality will provide:
an easy-to-use online application form which may result in real-time, instant approvals
greater efficiency and transparency of application information from NSW Ministry of Health
easily view, monitor and track active approval applications for the last two years
a centralised repository of all approval/authority information associated with your patients
What is being launched?
Initially it is anticipated that prescribers will be able to apply for Opioid Treatment Program (OTP) and schedule 8 Psychostimulant approval types. Additional approval types will be available in SafeScript NSW over the coming months.
How to access the new functionality?
This functionality will be integrated into the SafeScript NSW portal so prescribers who are registered for SafeScript NSW will be able to access the new functionality when it becomes available.
Pharmacists will be able to view summary OTP approval information including the approval number, start and end dates, and prescriber, patient, drug and dose information.
Prescribers and pharmacists who are not yet registered for SafeScript NSW can register for the system.
Support resources that will be available
An array of resources, such as detailed instructions, quick reference guides and videos, will be available on the SafeScript NSW Help section as well as the SafeScript NSW website.
HealthPathways
HealthPathways provides health professionals in Central and South-eastern Sydney with access to up-to-date clinical information and resources to support assessment, management, and referral of their patients.
To streamline the process for prescribing or supplying certain high-risk medicines, and to distinguish it from the Commonwealth PBS authorities, NSW Health are updating terminology currently used from ‘authorities’ to ‘approvals’. In SafeScript NSW, an approval is a reference to an authority issued under the Poisons and Therapeutic Goods Act. Please note that this transition will occur in alignment with the launch of SafeScript NSW’s new functionality.
More information about the SafeScript NSW approval management launch will be sent to all prescribers and other impacted users soon.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…